Inventor · disambiguated record
Daxin Gao
Also filed as: GAO DAXIN
12 granted patents·5 pending applications·109 citations·filing 2004–2022
88Inventor score
Top patents by PatentIndex Score
17 records- 0190US7320989B2Pyridine, pyrimidine, quinoline, quinazoline, and naphthalene urotensin-II receptor antagonistsENCYSIVE PHARMACEUTICALS INC·Filed 2004·Granted Jan 22, 2008·43 cites·4 claims
- 0289US7265122B2Pyridine, pyrimidine, quinoline, quinazoline, and naphthalene urotensin-II receptor antagonistsENCYSIVE PHARMACEUTICALS INC·Filed 2004·Granted Sep 4, 2007·49 cites·4 claims
- 0385US7579340B2Phenylenediamine urotensin-II receptor antagonists and CCR-9 antagonistsPFIZER·Filed 2007·Granted Aug 25, 2009·4 cites·6 claims
- 0474US7288538B2Phenylenediamine urotensin-II receptor antagonists and CCR-9 antagonistsENCYSIVE PHARMACEUTICALS INC·Filed 2004·Granted Oct 30, 2007·5 cites·7 claims
- 0568US7319111B2Phenylenediamine Urotensin-II receptor antagonists and CCR-9 antagonistsENCYSIVE PHARMACEUTICALS INC·Filed 2004·Granted Jan 15, 2008·4 cites·4 claims
- 0665US9216997B2Tri-heterocyclic derivatives, preparation process and uses thereofSHANGHAI DE NOVO PHARMATECH CO LTD·Filed 2012·Granted Dec 22, 2015·1 cites·9 claims
- 0765US8999985B2Substituted phthalazin-1(2H)-ones, preparation processes and medical uses thereofGAO DAXIN·Filed 2010·Granted Apr 7, 2015·2 cites·7 claims
- 0862US9914724B2C-aryl glycosid derivatives, pharmaceutical composition, preparation process and uses thereofSHANGHAI DE NOVO PHARMATECH CO LTD·Filed 2015·Granted Mar 13, 2018·1 cites·17 claims
- 0956US2024327425A1Kras g12d inhibitor and use thereofSHANGHAI DE NOVO PHARMATECH CO LTD·Filed 2022·Application pending·0 cites
- 1052US2008004312A1Pyridine, pyrimidine, quinoline, quinazoline, and naphthalene urotensin-II receptor antagonistsENCYSIVE PHARMACEUTICALS INC·Filed 2007·Application pending·0 cites
- 1150US2024025899A1Triheterocyclic derivative, and pharmaceutical composition and application thereofSHANGHAI DE NOVO PHARMATECH CO LTD·Filed 2021·Application pending·0 cites
- 1250US2024299572A1Nitrogen-containing compound, conjugate containing said compound, and application thereofSHANGHAI DE NOVO PHARMATECH CO LTD·Filed 2022·Application pending·0 cites
- 1343US12152051B2Cyclic dinucleotide analogue, pharmaceutical composition thereof, and applicationSHANGHAI DE NOVO PHARMATECH CO LTD·Filed 2019·Granted Nov 26, 2024·0 cites·17 claims
- 1441US11248006B2Macrocyclic derivative of pyrazol[3,4-d]pyrimidin-3-one, pharmaceutical composition and use thereofSHANGHAI DE NOVO PHARMATECH CO LTD·Filed 2018·Granted Feb 15, 2022·0 cites·20 claims
- 1537US10669252B2Benzazepine derivative, preparation method, pharmaceutical composition and use thereofSHANGHAI DE NOVO PHARMATECH CO LTD·Filed 2017·Granted Jun 2, 2020·0 cites·17 claims
- 1636US2012302534A1Derivatives of betulinGAO DAXIN·Filed 2011·Application pending·0 cites
- 1735US10202388B2Fused-ring compounds, pharmaceutical composition and uses thereofSHANGHAI DE NOVO PHARMATECH CO LTD·Filed 2016·Granted Feb 12, 2019·0 cites·20 claims
Join the waitlist — get patent alerts
Get an alert when Daxin Gao files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →